Results 301 to 310 of about 30,987,372 (386)

Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher, Charles B. Malpas, Stuart J. McDonald, William T. O’Brien, Craig Despott, Kelly L. Bertram, Matthew P. Pase, Lukas Frontzkowski, Meng Law, Terence J. O’Brien, Lucy Vivash   +10 more
wiley   +1 more source

Time-Dependent Predictive Accuracy Metrics in the Context of Interval Censoring and Competing Risks. [PDF]

Biom J
Yang Z, Rizopoulos D, Newcomb LF, Erler NS.   +3 more
europepmc   +1 more source

Case Report: Extending dosing intervals of biologics in adults severe asthma: a case series. [PDF]

Front Allergy
Harada T, Nishigami M, Tanaka H, Inui G, Ishikawa H, Kohno H, Funaki Y, Sakamoto T, Takata M, Okazaki R, Morita M, Kitatani S, Yamasaki A.   +12 more
europepmc   +1 more source

A practical ECG-based model for early identification of acute heart failure following acute myocardial infarction. [PDF]

Sci Rep
Guo X, Yan G, He H, Xu A, Zhan X, Gao G.
europepmc   +1 more source

QT Myopia and Cardiac Safety: Expanding the Aperture of Arrhythmia Assessment in Early Phase Drug Development. [PDF]

Clin Transl Sci
Lester RM, Clark K, Paglialunga S.
europepmc   +1 more source

Application of confidence intervals to data interpretation.

, 2016
Catherine R. Wagg, Grace P. S. Kwong, Daniel Pang   +2 more
openalex   +1 more source